The current hypothesis is that, in healthy individuals, iron deficiency stimulates FGF23 production whereby osteocytes couple increased production of FGF23 with increased cleavage to cFGF23 to maintain normal circulating levels of iFGF23, which is the biologically intact hormone [15]. The gene discussed is FGF23; the disease is Iron deficiency anemia.